Results 31 to 40 of about 1,974,567 (160)

Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal [PDF]

Journal of Stroke, 2018
The authors review the current status of percutaneous left atrial appendage (LAA) occlusion therapy in patients with atrial fibrillation with the goal to prevent ischemic stroke and systemic embolism and to reduce oral anticoagulation associated bleeding.
Peter D. Schellinger, Georgios Tsivgoulis, Thorsten Steiner, Martin Köhrmann   +3 more
doaj   +1 more source

Early postoperative interventional ASD-closure for severe atrial right to left shunt in a neonate with common arterial trunk [PDF]

, 2013
Although closure of an atrial septal defect (ASD II) with an occluding device in the first year of life is not a routine procedure, it is a feasible treatment, even in neonates.
Eicken, Andreas, Hess, John, Dilber, Daniel   +2 more
core   +1 more source

Transcatheter Extraction of a Migrated Left Atrial Appendage Occluder Device. [PDF]

JACC Case Rep
A 69-year-old man presented at 10 weeks postimplantation with a 31-mm Watchman FLX migrating into the left atrium. Due to incomplete left atrial appendage seal and embolization risk, transcatheter device extraction was performed without ...
Wong G, Aman E, Kiaii B, Rogers JH, Singh GD.   +4 more
europepmc   +2 more sources

Percutaneous Left Atrial Appendage Occlusion: A View From the UK [PDF]

, 2020
AF is associated with an increased risk of thromboembolic events, which is usually managed with oral anticoagulation therapy. However, despite a broad range of anticoagulant options and improved uptake in anticoagulation over the past decade, there are ...
Dhiraj Gupta, Ding, WY, Wern Yew Ding, Gupta, D   +3 more
core   +1 more source

Thrombus on the device early after the procedure of the left atrial appendage closure with the amplatzer cardiac plug: Is something wrong with the procedure or the device?

International Journal of the Cardiovascular Academy, 2019
Percutaneous left atrial appendage (LAA) closure is a currently utilized procedure for the prophylaxis of thromboembolic cerebrovascular events in selected patients with nonvalvular atrial fibrillation.
Baris Kilicaslan, Oner Ozdogan, Ali Kemal Cabuk, Inan Mutlu   +3 more
doaj   +1 more source

left atrial appendage occluder

, 2021
ObjectivesThis study aimed to present a new approach of thorough preclinical testing of a novel left atrial appendage (LAA) occluder device.BackgroundThe development of a safe and effective LAA occluder has been shown to be challenging.MethodsThe novel ...
Pornthep Lertsapcharoen, Ole De Backer, Aurelie Fabre, Lertsapcharoen, Pornthep, Fabre, Aurelie, Sondergaard, Lars, Lars Sondergaard, De Backer, Ole, Suphot Srimahachota, Foley, David, Hussein Hafiz, Srimahachota, Suphot, David Foley, Hafiz, Hussein   +13 more
core   +1 more source

Left atrial appendage closure using Amulet device in a patient with prior percutaneous atrial septal defect closure

Türk Kardiyoloji Derneği Arşivi, 2018
Percutaneous left atrial appendage (LAA) occlusion is an alternative therapeutic option for stroke prevention in patients with atrial fibrillation and contraindications for oral anticoagulation.
Cem Çöteli, Uğur Canpolat, Ergün Barış Kaya, Mehmet Levent Şahiner, Kudret Aytemir   +4 more
doaj   +1 more source

Closure Device-Related Thrombosis After Anticoagulation With Dabigatran in Patients Undergoing Percutaneous Left Atrial Appendage Closure: Case Reports and Literature Review

Frontiers in Pharmacology, 2020
Percutaneous left atrial appendage closure (LAAC) is an effective and safe operation strategy for stroke prevention in patients who are diagnosed with atrial fibrillation (AF) but cannot tolerate long term anticoagulation medication.
Xiaoye Li, Qinchun Jin, Xiaochun Zhang
doaj   +1 more source

Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders [PDF]

, 2023
AIMS Incomplete left atrial appendage occlusion (LAAO) due to peri-device leak (PDL) is a limitation of the therapy. The Amulet IDE trial is the largest randomized head-to-head trial comparing the Amulet and Watchman 2.5 LAAO devices with ...
Price, Matthew J, David Thaler, Nigel Gupta, Lakkireddy, Dhanunjaya, Anderson, Jordan A, Ryan Gage, Alok Gambhir, Gupta, Nigel, Gage, Ryan, Matthew J Price, Anuj Mediratta, Christopher R Ellis, Thaler, David, Jens Erik Nielsen-Kudsk, Windecker, Stephan, Nielsen-Kudsk, Jens Erik, Leo Marcoff, Jordan A Anderson, Marcoff, Leo, Dhanunjaya Lakkireddy, Stephan Windecker, Konstantinos Koulogiannis, Gambhir, Alok, Koulogiannis, Konstantinos, Ellis, Christopher R, Mediratta, Anuj   +25 more
core   +2 more sources

Successful percutaneous left atrial appendage occlusion for atrial fibrillation in a patient with mirror-image dextrocardia: a case report

BMC Cardiovascular Disorders, 2022
Background Dextrocardia is a rare congenital condition (1/10,000–12,000) and AF is uncommon (1–2%). Therefore, the occurrence of the two conditions is rare. Percutaneous left atrial appendage occlusion (LAAO) is a treatment to prevent atrial fibrillation
Jizhe Xu, Gaxue Jiang, Lu Zhang, Zixian Chen, Hao Wang, Ming Bai, Jie Zeng   +6 more
doaj   +1 more source